Company chart and information is provided by TradingView based on 15-minute-delayed data.
Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex mite nervous system to kill the mites.
| Website: | www.tarsusrx.com |
| Email: | info@tarsusrx.com |
| Main Phone: | +1 949 409-9820 |
| Address: | 15440 Laguna Canyon Road |
| Address 2: | Suite 160 |
| State: | CA |
| City / Town: | Irvine |
| Country: | US |
| Postal Code: | 92618 |
| Exchange: | NGS |
| CEO: | Bobak Azamian |
| Employees: | 18 |
| NAICS: | Research and Development in Biotechnology (except Nanobiotechnology)(541714) |
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
